Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) Director Mika Derynck Sells 158,795 Shares

Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) Director Mika Derynck sold 158,795 shares of Bitwise MARA Option Income Strategy ETF stock in a transaction that occurred on Tuesday, August 4th. The shares were sold at an average price of $60.21, for a total value of $9,561,046.95. Following the completion of the sale, the director directly owned 87,373 shares in the company, valued at approximately $5,260,728.33. This represents a 64.51% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Bitwise MARA Option Income Strategy ETF Stock Performance

NYSEARCA IMRA opened at $14.59 on Friday. The stock has a market capitalization of $1.90 million, a price-to-earnings ratio of 291.80 and a beta of 2.74. The stock’s 50 day moving average price is $16.10 and its two-hundred day moving average price is $15.36. Bitwise MARA Option Income Strategy ETF has a 52 week low of $11.99 and a 52 week high of $42.32.

Bitwise MARA Option Income Strategy ETF Company Profile

IMARA Inc, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2?related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas.